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The Increasing Prevalence of Haemophilia
Dear Sir, Treatment of haemophiha patients depends on an adequate supply of blood products As long äs clottmg factor preparations produced by recombmant DNA techmques are not widely available, changes m the number of patients may threaten the precious balance of blood donations and plasma products consumption
The observed prevalence of haemophiha is the resultant of the prevalence at birth and mortahty It may be affected by genetic counsehng of carner women and selective abortion and also by the fertility of patients Until only 20 years ago haemophiha patients had a hfe expectancy less than 30 years (1), and therefore the prevalence we observe today will be much smaller than the prevalence at birth Nowadays, hfe expectancy is only mildly reduced (2), aside from the present AIDS mortahty which differs from country to country The present longevity of haemophiha patients will therefore lead to an mcrease m their number This is illustrated m Fig l, which shows the prevalence of haemophiha per age group in The Netherlands These data were obtamed by a survey of all registered 1,162 Dutch haemophiha patients Information was available for 80% of the patients, the prevalence date have been extended to all 1,162 In each age group the number of patients m divided by the total number of men m The Netherlands of that age (3) Up to age 20 (mid mterval) the prevalence mcreases This is likely to be caused by delays in diagnosis, mamly of mild haemophiha After age 40 (mid mterval), there is a steady declme of the age specific prevalence This deficit of older patients can only be explamed by excess mortahty in the past The plateau of 20 6 per 100,000 males approximates the prevalence at birth If this prevalence were present at all ages, the number of haemophiha patients would be almost 1,500, i e 28% more than the present number of haemophiha patients m The Netherlands At the moment the mortahty m haemophiha is twice äs high äs in the general population, aside from AIDS mortahty This leads, äs calculated by hfe table method, to a reduction m the overall prevalence of about 10% Prenatal diagnosis and selective abortion might affect the prevalence at birth, this effect will be minimal however, since we found m a recent survey of 549 female relatives of haemophiha patients that only a minonty of carriers choose for this Option (4), which corroborates reports from the United Kingdom (5) Furthermore, we noted that the younger patients were relatively more often married than the older patients Haemophiha patients had on average less children than men m the general population, which was partly caused by their being less often married, and partly by genetic and physical considerations The improved physical condition of haemophiha patients is therefore likely to lead to an mcrease in the number of carner daughters of haemophiha patients, and m two generations this will cause a further mcrease in the prevalence at birth
The number of HIV positive haemophiha patients and the ensuing mortahty differ widely from one country to another In The Netherlands the number of infected patients is relatively low (less than 20%) (6), and therefore the nse m the number of patients will occur m one generation In countnes m which the majonty of patients is HIV positive, excess mortahty may at first lower the prevalence, but this will be a temporary effect The attitude towards prenatal diagnosis may also be different m other countnes Nevertheless, we thmk that the substantial growth m 
